Research and analysis

Intravenous immunoglobulin for the treatment of invasive PVL-SA

Use of intravenous immunoglobulin for the treatment of invasive PVL-SA infection in hospital inpatients.

• From: UK Health Security Agency
• Published: 21 August 2025

Documents

Intravenous immunoglobulin in the treatment of invasive Panton-Valentine Leukocidin Staphylococcus: a rapid systematic review

Ref: Published August 2025

PDF, 432 KB, 30 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This rapid systematic review identified and summarised evidence on the use of intravenous immunoglobulin as treatment for invasive Panton-Valentine Leukocidin Staphylococcus aureus infections in hospital inpatients.

This rapid systematic review searched for research published up to 18 December 2024. Seven case reports were included.

Published 21 August 2025